Company
iThriveMD
iThriveMD publishes compounded semaglutide and compounded tirzepatide, from $299 to $399 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from ithrivemd.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to iThriveMD
We earn nothing from this link. iThriveMD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Monthly (no commitment), after first month
first month, including the required fees on record · Monthly (no commitment), after first month
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Local clinics in Southern/Northern California and Arizona plus a 'Virtual appointments/Telehealth' option. /policy/terms-of-use/ and /weight-loss/ pages returned essentially empty visible-text bodies to this tool (heavily JS-rendered), so states-served, prescriber sync/async, and cancellation policy could not be verified despite checking. Microdosing Tirzepatide plan description: 'This price covers your first 30-minute consultation, monthly 15-minute follow-up visits, and up to 3 mg of tirzepatide each week.'
Before you act
Cite this
Treatment Registry. (2026). iThriveMD: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/ithrivemd